Spots Global Cancer Trial Database for A Study of Niraparib (GSK3985771) Maintenance Treatment in Participants With Advanced Ovarian Cancer Following Response on Front-Line Platinum-Based Chemotherapy
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: A Study of Niraparib (GSK3985771) Maintenance Treatment in Participants With Advanced Ovarian Cancer Following Response on Front-Line Platinum-Based Chemotherapy
Official Title: A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of Niraparib Maintenance Treatment in Patients With Advanced Ovarian Cancer Following Response on Front-Line Platinum-Based Chemotherapy
Study ID: NCT02655016
Conditions
Study Description
Brief Summary: This study aims to assess efficacy of Niraparib (GSK3985771) as maintenance treatment in participants with Stage III or IV ovarian cancer. Participants must have completed front-line platinum based regimen with complete response (CR) or partial response (PR). Data collection for Secondary Outcome measures is ongoing and the approximate duration of the study will be 7 years.
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: FEMALE
Healthy Volunteers: No
Locations
GSK Investigational Site, Mesa, Arizona, United States
GSK Investigational Site, Tucson, Arizona, United States
GSK Investigational Site, Tucson, Arizona, United States
GSK Investigational Site, Los Angeles, California, United States
GSK Investigational Site, San Francisco, California, United States
GSK Investigational Site, San Francisco, California, United States
GSK Investigational Site, Santa Rosa, California, United States
GSK Investigational Site, Hartford, Connecticut, United States
GSK Investigational Site, New Haven, Connecticut, United States
GSK Investigational Site, Hollywood, Florida, United States
GSK Investigational Site, Jacksonville, Florida, United States
GSK Investigational Site, Miami, Florida, United States
GSK Investigational Site, Atlanta, Georgia, United States
GSK Investigational Site, Augusta, Georgia, United States
GSK Investigational Site, Savannah, Georgia, United States
GSK Investigational Site, Chicago, Illinois, United States
GSK Investigational Site, Hinsdale, Illinois, United States
GSK Investigational Site, Warrenville, Illinois, United States
GSK Investigational Site, Indianapolis, Indiana, United States
GSK Investigational Site, Indianapolis, Indiana, United States
GSK Investigational Site, Iowa City, Iowa, United States
GSK Investigational Site, Baton Rouge, Louisiana, United States
GSK Investigational Site, Covington, Louisiana, United States
GSK Investigational Site, New Orleans, Louisiana, United States
GSK Investigational Site, Baltimore, Maryland, United States
GSK Investigational Site, Silver Spring, Maryland, United States
GSK Investigational Site, Burlington, Massachusetts, United States
GSK Investigational Site, Springfield, Massachusetts, United States
GSK Investigational Site, Grand Rapids, Michigan, United States
GSK Investigational Site, Minneapolis, Minnesota, United States
GSK Investigational Site, Springfield, Missouri, United States
GSK Investigational Site, Middletown, New Jersey, United States
GSK Investigational Site, Neptune, New Jersey, United States
GSK Investigational Site, Teaneck, New Jersey, United States
GSK Investigational Site, Buffalo, New York, United States
GSK Investigational Site, Harrison, New York, United States
GSK Investigational Site, Mineola, New York, United States
GSK Investigational Site, New York, New York, United States
GSK Investigational Site, New York, New York, United States
GSK Investigational Site, Rochester, New York, United States
GSK Investigational Site, Chapel Hill, North Carolina, United States
GSK Investigational Site, Wilmington, North Carolina, United States
GSK Investigational Site, Cleveland, Ohio, United States
GSK Investigational Site, Cleveland, Ohio, United States
GSK Investigational Site, Columbus, Ohio, United States
GSK Investigational Site, Mayfield Heights, Ohio, United States
GSK Investigational Site, Oklahoma City, Oklahoma, United States
GSK Investigational Site, Tulsa, Oklahoma, United States
GSK Investigational Site, Portland, Oregon, United States
GSK Investigational Site, Springfield, Oregon, United States
GSK Investigational Site, Philadelphia, Pennsylvania, United States
GSK Investigational Site, Willow Grove, Pennsylvania, United States
GSK Investigational Site, Providence, Rhode Island, United States
GSK Investigational Site, Charleston, South Carolina, United States
GSK Investigational Site, Sioux Falls, South Dakota, United States
GSK Investigational Site, Austin, Texas, United States
GSK Investigational Site, Fort Worth, Texas, United States
GSK Investigational Site, San Antonio, Texas, United States
GSK Investigational Site, The Woodlands, Texas, United States
GSK Investigational Site, Tyler, Texas, United States
GSK Investigational Site, Salt Lake City, Utah, United States
GSK Investigational Site, Kennewick, Washington, United States
GSK Investigational Site, Seattle, Washington, United States
GSK Investigational Site, Spokane, Washington, United States
GSK Investigational Site, Morgantown, West Virginia, United States
GSK Investigational Site, Milwaukee, Wisconsin, United States
GSK Investigational Site, Bonheiden, , Belgium
GSK Investigational Site, Bruxelles, , Belgium
GSK Investigational Site, Bruxelles, , Belgium
GSK Investigational Site, Charleroi, , Belgium
GSK Investigational Site, Gent, , Belgium
GSK Investigational Site, Hasselt, , Belgium
GSK Investigational Site, Leuven, , Belgium
GSK Investigational Site, Libramont, , Belgium
GSK Investigational Site, Namur, , Belgium
GSK Investigational Site, Sint-Niklaas, , Belgium
GSK Investigational Site, Calgary, Alberta, Canada
GSK Investigational Site, Kelowna, British Columbia, Canada
GSK Investigational Site, Surrey, British Columbia, Canada
GSK Investigational Site, Vancouver, British Columbia, Canada
GSK Investigational Site, Barrie, Ontario, Canada
GSK Investigational Site, London, Ontario, Canada
GSK Investigational Site, Ottawa, Ontario, Canada
GSK Investigational Site, Toronto, Ontario, Canada
GSK Investigational Site, Toronto, Ontario, Canada
GSK Investigational Site, Montreal, Quebec, Canada
GSK Investigational Site, Montreal, Quebec, Canada
GSK Investigational Site, Montréal, Quebec, Canada
GSK Investigational Site, Brno, , Czechia
GSK Investigational Site, Ostrava, , Czechia
GSK Investigational Site, Plzen-Lochotin, , Czechia
GSK Investigational Site, Prague, , Czechia
GSK Investigational Site, Prague, , Czechia
GSK Investigational Site, Aalborg, , Denmark
GSK Investigational Site, Herlev, , Denmark
GSK Investigational Site, Koebenhavn Oe, , Denmark
GSK Investigational Site, Odense, , Denmark
GSK Investigational Site, Kuopio, , Finland
GSK Investigational Site, Oulu, , Finland
GSK Investigational Site, Tampere, , Finland
GSK Investigational Site, Turku, , Finland
GSK Investigational Site, Angers, , France
GSK Investigational Site, Caen Cedex 05, , France
GSK Investigational Site, Montpellier Cedex 5, , France
GSK Investigational Site, Nice Cedex 2, , France
GSK Investigational Site, Paris, , France
GSK Investigational Site, Pierre-Benite cedex, , France
GSK Investigational Site, Rennes Cedex, , France
GSK Investigational Site, Saint-Herblain, , France
GSK Investigational Site, Heidelberg, Baden-Wuerttemberg, Germany
GSK Investigational Site, Mannheim, Baden-Wuerttemberg, Germany
GSK Investigational Site, Fuerth, Bayern, Germany
GSK Investigational Site, Muenchen, Bayern, Germany
GSK Investigational Site, Muenchen, Bayern, Germany
GSK Investigational Site, Goettingen, Niedersachsen, Germany
GSK Investigational Site, Essen, Nordrhein-Westfalen, Germany
GSK Investigational Site, Ludwigshafen, Rheinland-Pfalz, Germany
GSK Investigational Site, Berlin, , Germany
GSK Investigational Site, Hamburg, , Germany
GSK Investigational Site, Debrecen, , Hungary
GSK Investigational Site, Gyor, , Hungary
GSK Investigational Site, Galway, , Ireland
GSK Investigational Site, Waterford, , Ireland
GSK Investigational Site, Beer Sheva, , Israel
GSK Investigational Site, Haifa, , Israel
GSK Investigational Site, Haifa, , Israel
GSK Investigational Site, Holon, , Israel
GSK Investigational Site, Tel Aviv, , Israel
GSK Investigational Site, Tel Hashomer, , Israel
GSK Investigational Site, Napoli, Campania, Italy
GSK Investigational Site, Modena, Emilia-Romagna, Italy
GSK Investigational Site, Milano, Lombardia, Italy
GSK Investigational Site, Milano, Lombardia, Italy
GSK Investigational Site, Candiolo (TO), Piemonte, Italy
GSK Investigational Site, Mirano, Veneto, Italy
GSK Investigational Site, Oslo, , Norway
GSK Investigational Site, Lodz, , Poland
GSK Investigational Site, Lublin, , Poland
GSK Investigational Site, Olsztyn, , Poland
GSK Investigational Site, Poznan, , Poland
GSK Investigational Site, Arkhangelsk, , Russian Federation
GSK Investigational Site, Chelyabinsk, , Russian Federation
GSK Investigational Site, Irkutsk, , Russian Federation
GSK Investigational Site, Ivanovo, , Russian Federation
GSK Investigational Site, Kazan, , Russian Federation
GSK Investigational Site, Krasnoyarsk, , Russian Federation
GSK Investigational Site, Orenburg, , Russian Federation
GSK Investigational Site, Pyatigorsk, , Russian Federation
GSK Investigational Site, Saint-Petersburg, , Russian Federation
GSK Investigational Site, Samara, , Russian Federation
GSK Investigational Site, St-Petersburg, , Russian Federation
GSK Investigational Site, St. Petersburg, , Russian Federation
GSK Investigational Site, St. Petersburg, , Russian Federation
GSK Investigational Site, Badalona, , Spain
GSK Investigational Site, Barcelona, , Spain
GSK Investigational Site, Barcelona, , Spain
GSK Investigational Site, Barcelona, , Spain
GSK Investigational Site, Cordoba, , Spain
GSK Investigational Site, Elche, , Spain
GSK Investigational Site, Girona, , Spain
GSK Investigational Site, Hospitalet de Llobregat, Barcelona, , Spain
GSK Investigational Site, Madrid, , Spain
GSK Investigational Site, Madrid, , Spain
GSK Investigational Site, Madrid, , Spain
GSK Investigational Site, Madrid, , Spain
GSK Investigational Site, San Sebastián, , Spain
GSK Investigational Site, Sevilla, , Spain
GSK Investigational Site, Sevilla, , Spain
GSK Investigational Site, Valencia, , Spain
GSK Investigational Site, Valencia, , Spain
GSK Investigational Site, Zaragoza, , Spain
GSK Investigational Site, Stockholm, , Sweden
GSK Investigational Site, Uppsala, , Sweden
GSK Investigational Site, Basel, , Switzerland
GSK Investigational Site, Bern, , Switzerland
GSK Investigational Site, Frauenfeld, , Switzerland
GSK Investigational Site, Zurich, , Switzerland
GSK Investigational Site, Dnipropetrovsk, , Ukraine
GSK Investigational Site, Dnipro, , Ukraine
GSK Investigational Site, Ivano-Frankivsk, , Ukraine
GSK Investigational Site, Kharkiv, , Ukraine
GSK Investigational Site, Kherson, , Ukraine
GSK Investigational Site, Krivoy Rog, , Ukraine
GSK Investigational Site, Kyiv, , Ukraine
GSK Investigational Site, Vinnitsia, , Ukraine
GSK Investigational Site, Zaporizhzhia, , Ukraine
GSK Investigational Site, Portsmouth, Hampshire, United Kingdom
GSK Investigational Site, Bath, Somerset, United Kingdom
GSK Investigational Site, Stoke-on-Trent, Staffordshire, United Kingdom
GSK Investigational Site, Blackburn, , United Kingdom
GSK Investigational Site, Exeter, , United Kingdom
GSK Investigational Site, Glasgow, , United Kingdom
GSK Investigational Site, London, , United Kingdom
GSK Investigational Site, Sheffield, , United Kingdom
GSK Investigational Site, Truro, , United Kingdom
Contact Details
Name: GSK Clinical Trials
Affiliation: GlaxoSmithKline
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
